- Country: Belgium
- Summary: Development and Production of Challenge Agents in the Context of Clinical Studies Carried out in Vaccinopolis
- BET Ref No: 121971021
- Deadline: 01 Aug 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: 430025-2025
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Vaccinopolis, the contracting authority, is a clinical research site that carries out ambulatory studies and human provocation studies or controlled human Infection Model (Chim) studies. In order to guarantee a high -quality operation of the research site, Vaccinopolis wants to draw up a framework agreement for The development and production of Challenge Agents in the context of the (Chim) studies carried out within Vaccinopolis. The contracting authority is looking for a qualified party that is able to develop and produce Challenge Agents according to the applicable Good Manufacturing Practice (GMP) guidelines. These Challenge Agents will be used in (Chim) studies, where healthy volunteers are infected in a controlled manner with a pathogen to evaluate the efficacy of vaccines or treatments.
25082 - 1
Vaccinopolis, the contracting authority, is a clinical Research site that carries out ambulatory studies and human provocation studies or controlled human infection model (Chim) studies. In order to guarantee a high -quality operation of the research site, Vaccinopolis wants to draw up a framework agreement for the development and production of Challenge Agents in The framework of the (Chim) studies carried out within Vaccinopolis.
The contracting authority is looking for a qualified party capable of is to develop and produce Challenge Agents according to the applicable Good Manufacturing Practice (GMP) guidelines. This challenge agents to... - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINDevelopment and Production of Challenge Agents in the Context of Clinical Studies Carried out in Vaccinopolis - Belgium Tender
The UNIVERSITY ANTWERP, a Government sector organization in Belgium, has announced a new tender for Development and Production of Challenge Agents in the Context of Clinical Studies Carried out in Vaccinopolis. This tender is published on BelgiumTenders under BET Ref No: 121971021 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-08-01.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
